J. Li et al. / Inorganica Chimica Acta 364 (2010) 185–194
187
CHCl3, and the solution was dried over Na2SO4. Concentration of
the filtrate after the removal of the drying agent afforded a white
waxy solid: m.p.: 111–112 °C; 1H NMR (CDCl3, 360.15 MHz) d
1.27 (br s, 4H, NH2), 2.95 (t, 4H, J = 6.3 Hz, CH2CH2NH2), 3.54 (t,
4H, J = 6.3 Hz, CH2CH2NH2), 3.64 (s, 4H, NCH2CH2N); 13C NMR
(CDCl3, 90.56 MHz, ref. central line of CDCl3 set at 77.23 ppm) d
39.92, 45.60, 50.76, 158.02; IR (KBr) 3387.7 (NH asym.), 3317
(NH sym.), 1667 cmꢁ1; MS (CI, isobutane) m/z 183.2 (M-18+1) [16].
in the precipitation of a white solid. After filtration, the product
was washed with additional MeOH and dried under reduced pres-
sure to give a white powder. Clear, colorless cubic crystals were
harvested after Et2O diffusion into a DMF solution of this powder
over several days (112 mg, 65% yield). 1H NMR (CD3CN,
399.75 MHz): d 1.93 (m, 4H), 3.37 (t, 4H), 3.42 (s, 4H), 3.51 (t,
4H); 13C{1H} NMR (CD3CN, 100.52 MHz, ref. CD3CN set at
117.6 ppm) d 20.1, 44.9, 46.6, 47.4, 148.0; MS (EI): 429.3 amu
{[Hg(L2)Cl]+}; IR (KBr): 1608 cmꢁ1 (N@C–C@N); Anal. Calc. for
Hg(C10H16N4)Cl2: C, 25.90; H, 3.48; N, 12.08; Cl, 15.29. Found: C,
25.99; H, 3.50; N, 11.93; Cl, 15.10%.
2.2.4. [Pd(L2)2](BF4)2, complex 1
An amount of Pd(CH3CN)4(BF4)2 (250 mg, 0.563 mmol) was dis-
solved in CH3CN (5 mL). Addition of 4.4 mL (222 mg, 0.5 mmol)
CH3CN of this solution by syringe to L2 (194 mg, 1.01 mmol) in a
flask resulted in a yellow solution. The reaction mixture was stirred
at room-temperature for 4 h. The solution was then transferred to
test tubes for crystallization by slow Et2O diffusion. Yellow needles
(236 mg, 71% yield) of complex 1 were harvested. 1H NMR (CD3CN,
399.75 MHz): d 1.95 (m, 4H), 3.39 (t, 4H), 3.40 (t, 4H), 3.45
(s, 4H); 13C{1H} NMR (CD3CN, 100.51 MHz, ref. CD3CN set at
117.6 ppm): d 20.1, 46.3, 46.8, 48.7, 155.0; IR (KBr): 1612 cmꢁ1
(N@C–C@N); ESI-MS: 557.1 amu {[Pd(L2)2(BF4)]+}; Anal. Calc. for
Pd(C10H16N4)2(BF4)2ꢂ(H2O)1.5: C, 34.74; H, 5.10; N, 16.20. Found:
C, 34.78; H, 4.84; N, 16.30%.
2.2.9. [Hg(L1)Cl2]2, complex 6
An amount of HgCl2 (38.4 mg, 0.103 mmol) was dissolved in
5 mL methanol. Upon addition of a methanol solution of L1
(84.5 mg, 0.515 mmol in 5 mL) a white precipitate formed. After
filtration, this solid was washed with methanol and dried under re-
duced pressure to give product as a white powder (34.5 mg, 86%
yield). This was recrystallized from DMSO by ether diffusion to give
1
clear cubic crystals. H NMR ((CD3)2SO): d 3.73–3.80 (AA0XX0, 4H),
3.55–3.70 (AA0XX0, 4H), 3.41 (s, 4H); 13C{1H} NMR ((CD3)2SO, ref.
center line of (CD3)2SO set at 39.51 ppm) d 43.4, 51.7, 52.7,
154.7; IR (KBr): 1624, 1543 cmꢁ1 (N@C–C@N); Anal. Calc. for
Hg(C8H12N4)Cl2: C, 22.05; H, 2.78; N, 12.86. Found: C, 22.22; H,
2.72; N, 12.67%.
2.2.5. [Pd2(L1)4]Br4, complex 2
An amount of Pd(PhCN)2Br2 (114 mg, 0.241 mmol) and 2.20
equivalents of L1 (90.8 mg, 0.553 mmol) were dissolved in 7 mL
DMSO to give an orange solution. After stirring for 30 min, diethyl
ether was slowly diffused in to give a yellow solid (134 mg, 23%
yield). 1H NMR (CD3OD, 499.775 MHz): d 3.66 (s, 4H), 3.89–3.94
(AA0XX0, 4H), 4.19–4.24 (AA0XX0, 4H); 13C{1H} NMR (CD3OD,
125.67 MHz, ref. CD3CN set at 117.6 ppm): d 42.52, 49.47, 54.47,
153.63; IR (KBr): 1605, 1533 cmꢁ1 (N@C–C@N); UV–Vis (DMSO):
2.2.10. [Cu(L2)3](ClO4)2, complex 7
Addition of an amount of Cu(ClO4)2ꢂ(H2O)6 (37.2 mg,
0.101 mmol) to a solution of L2 (58.3 mg, 0.303 mmol) in MeCN
(5 mL) resulted in the formation of a light blue solution. After stir-
ring for 1 h, the solution was transferred to small vials for crystal-
lization by diethyl ether diffusion. Clear, green X-ray quality
crystals were harvested after several days.
A total mass of
315 nm
(
e
= 50,200 Mꢁ1 cmꢁ1);
ESI-MS:
1106.5 amu
51.0 mg (60% yield) of the crystals were collected. IR (KBr pellet):
1615 cmꢁ1 (N@C–C@N); Anal. Calc. for Cu(C10H16N4)3(ClO4)2ꢂ
(H2O): C, 42.03; H, 5.88; N, 19.61; Cl, 8.27. Found: C, 42.05; H,
5.83; N, 19.35; Cl, 8.18%.
{[Pd2(L1)4]Br3]+}; Anal. Calc. for Pd2(C8H12N4)2Br4ꢂ(H2O)4: C,
30.47; H, 4.48; N, 17.77; Br, 25.34. Found: C, 30.05; H, 4.55; N,
17.71; Br, 24.99%.
2.2.6. Zn(L1)3(NO3)2, complex 3
2.2.11. [Cu(L2)2](ClO4)2, complex 8
An amount of Zn(NO3)2ꢂ6H2O (34.1 mg, 0.114 mmol) and a
slight excess of three equivalents of L1 (59.0 mg, 0.360 mmol) were
dissolved in acetonitrile (5 mL) with stirring. The clear solution
was subjected to ether diffusion. Clear rhombic crystals (54.6 mg,
0.0801 mmol, 70%) of 3 grew after 3 days. 1H NMR (CD3CN): d
3.41 (s, 4H), 3.55–3.73 (AA0XX0, 4H), 3.75–3.93 (AA0XX0, 4H);
13C{1H} NMR (CD3CN, ref. CD3CN set at 117.6 ppm): d 44.93,
53.02, 53.61, 156.64; IR (KBr): 1641, 1628, 1582, 1547 cmꢁ1
(N@C–C@N); Anal. Calc. for Zn(C8H12N4)3(NO3)2: C, 42.27; H,
5.32; N, 28.75. Found: C, 42.09; H, 5.37; N, 28.97%.
An amount of Cu(ClO4)2ꢂ(H2O)6 (58.2 mg, 0.157 mmol) and two
equivalents of L2 (59.6 mg, 0.310 mmol) were combined in a flask.
A blue precipitate formed immediately when EtOH (5 mL) was
added into the flask. The product was collected by filtration and
washed with additional MeOH, dried under reduced pressure to
give a blue powder (65.7 mg, 66% yield). Clear, dark blue needle
crystals were harvested after Et2O diffusion into a CH3CN solution
of this powder over several days. IR (KBr): 1623 cmꢁ1 (N@C–C@N);
Anal. Calc. for Cu(C10H16N4)2(ClO4)2: C, 37.13; H, 4.99; N, 17.32; Cl,
10.96. Found: C, 37.61; H, 5.00; N, 17.45%.
2.2.7. Zn(L2)3(ClO4)2, complex 4
2.2.12. [Ag(L2)2](BF4), complex 9
Addition of an amount of Zn(ClO4)2ꢂ6H2O (38.6 mg,
0.104 mmol) to a solution of L2 (61.2 mg, 0.318 mmol) in CH3CN
(20 mL) formed a colorless solution. After stirring for 2 h, this solu-
tion was transferred to vials for crystallization by diethyl ether dif-
fusion. X-ray quality colorless crystals of 4 were harvested over
several days (44 mg, 50% yield). 1H NMR (CD3CN, 399.75 MHz): d
1.70–1.85 (2m, 3 ꢃ 4H), 3.02–3.60 (m, 3 ꢃ 12H); 13C{1H} NMR
(CD3CN, 100.53 MHz, ref. CD3CN set at 117.7 ppm) d 20.4, 42.5,
46.6, 47.3, 147.3; IR (KBr): 1614 cmꢁ1 (N@C–C@N); Anal. Calc. for
Zn(C10H16N4)3(ClO4)2: C, 42.84; H, 5.75; N, 19.78; Cl, 8.43. Found:
C, 42.61; H, 5.81; N, 19.71; Cl, 8.64%.
Addition of AgBF4 (28.9 mg, 0.148 mmol) to a solution of L2
(62.1 mg, 0.323 mmol) in MeCN (6 mL) generated a light yellow
solution. This MeCN solution was transferred to test tubes for
recrystallization by ether diffusion. Light yellow crystals
(38.9 mg, 45% yield) were harvested from the solution after several
days in the dark. 1H NMR (CD3CN, 399.75 MHz, ref. center line of
CD2HCN set at 1.96 ppm): d 1.85 (m, 4H), 3.30 (t, 4H), 3.32 (s,
4H), 3.46 (t, 4H); 13C{1H} NMR (CD3CN, 100.52 MHz, ref. CD3CN
set at 117.6 ppm) d 20.7, 46.95, 46.98, 47.6, 148.4; IR (KBr):
1626, 1596 cmꢁ1 (N@C–C@N); Anal. Calc. for Ag(C10H16N4)2(BF4):
C, 41.47; H, 5.57; N, 19.35. Found: C, 41.58; H, 5.64; N, 19.28%.
2.2.8. [Hg(L2)2](HgCl4), complex 5
2.2.13. [Ag(L2)2](BPh4), complex 10
Addition of an amount of HgCl2 (95.3 mg, 0.351 mmol) to a
solution of L2 (71.1 mg, 0.370 mmol) in MeOH (15 mL) resulted
Addition of a solution of AgBF4 (48.8 mg, 0.251 mmol) in EtOH
(2 mL) to a solution of L2 (99.2 mg, 0.516 mmol) in EtOH (3 mL)